title: [Cyclosporin A therapy in pyoderma gangraenosum].
abstract: A 33-year-old woman with pyoderma gangrenosum was treated with cyclosporine A. Cyclosporine A is a valuable drug for the treatment of recalcitrant pyoderma gangrenosum. Its mechanism of action is discussed. The numerous side-effects require close monitoring of cyclosporine A blood levels and several other parameters.
authors.affiliation: Hautklinik, Heinrich-Heine-Universität Düsseldorf.
authors.forename: M
authors.initials: M
authors.lastname: Zumdick
authors.forename: H C
authors.initials: HC
authors.lastname: Schuppe
authors.forename: G
authors.initials: G
authors.lastname: Goerz
mesh_terms: D000328:Adult; D016572:Cyclosporine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007868:Leg Dermatoses / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D008111:Liver Function Tests; D008657:Metabolic Clearance Rate; D017511:Pyoderma Gangrenosum / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D012867:Skin / Q000473:pathology
chemical_list: D016572:Cyclosporine
vernacular_title: Cyclosporin-A-Therapie bei Pyoderma gangraenosum.